Entries by Mediplus Pharma

Antioxidant

A generic term for substances that inhibit the generation and function of reactive oxygen species or remove reactive oxygen species themselves. Antioxidants include antioxidant enzymes synthesized in the body, such as superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT), and antioxidants taken in from food, such as polyphenols, carotenoids, and vitamins.

Antioxidation

Antioxidants inhibit the body from oxidizing, which is called antioxidant, antioxidant capacity, or antioxidant action. Antioxidants inhibit the action of reactive oxygen species (ROS) to prevent the body from being affected by oxidation in various ways.

Hormesis

A phenomenon in which a substance is harmful when used in high concentrations or in large quantities, but is beneficial to the body when used in low concentrations or in small quantities. For example, exposure to large amounts of ultraviolet rays can cause skin cancer, but small amounts of ultraviolet rays are necessary for the body to produce active vitamin […]

SID(Society Investigate Dermatology)

The world prominent scientific research organization, which is composed of scientists in skin health and disease. The headquarters locate in Cleveland, Ohio, U.S.A, consists of members representing 32 countries. The annual convention is thought as the world’s highest-level conference in fundamental research of dermatology. The journals published regularly are highly prestigious, with the 5th highest Impact Factor in Dermatology section […]

Features of the cosmetic ingredient Ozonized Glycerin

Ozonized Glycerin is a cosmetic ingredient made from glycerin that has been greatly enhanced to a highly functional ingredient through a patented “ozonation” process. A novel, patented ozonation process was used to create zonized Glycerin , a new proprietary substance of natural origin made from glycerin that is gentle on the skin. This process was discovered during the drug discovery […]

Mediplus Pharma’s article “Ozonized glycerin (OG)-based cosmetic products lighten age spots on human facial skin” was accepted into the “Journal of Cosmetic Dermatology” and used as the journal cover

Cover page of the “Journal of Cosmetic Dermatology” (USA), an international academic journal of cosmetic dermatology and human clinical sciences. Mediplus Pharma Inc. (Representative Director Kenji Ito, head office: Shibuya-ku, Tokyo) announces that the article on Mediplus Pharma’s patented ingredient: ozonized glycerin titled “Ozonized glycerin (OG)-based cosmetic products lighten age spots on human facial skin” was accepted into the American […]

Mediplus Pharma is presenting posters at Society for Investigative Dermatology(SID)annual meeting 2022

Mediplus Pharma, Inc. (CEO: Kenji Ito, Head Office: Shibuya-ku, Tokyo,JAPAN) made a scientific presentation at the annual meeting of the Society for Investigative Dermatology (May 18-21, 2022, Portland, USA), which is considered the world’s highest-level society in dermatological research. Title:Novel glycerin compounds improve skin health